Benzodiazepines (Oral, Nasal, Rectal)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

Refer to the Sedative/Hypnotics criteria for sedative and hypnotic benzodiazepines.

• Revision history
  • April 22, 2022; March 2020; March 2018; May 2017; Dec. 2014; March 2013; June 2011; Jan. 2009; April 2003; Dec. 2001; Dec. 2000; Dec. 1999; Nov. 1998; Nov. 1997; Dec. 1996.
• Initially developed
  • Oct. 1993